c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
LifeMD outlines $46M-$49M Q4 revenue outlook while targeting a 30% opex reduction by Q1 2027
Seeking Alpha | Nov 13, 2026 4:40 AM EST
Read original article